Apnar Pharma Private Limited, a active private limited company, was established on 12 December 2014 in Padra, Gujarat, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U73100GJ2014PTC081520. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.60 Cr and a paid-up capital of ₹7.55 Cr.
Formerly known as Apnar Research Pharma Private Limited. It upholds a compliant status. Employing 95 professional, Its leadership includes Umesh Patel (Director), Dharmesh Bhikhabhai Patel (Director), Swapnil Kantibhai Patel (Director). Past directors included Kantibhai Bavabhai Patel, Bhavesh Kishor Jagtap. It holds ₹50.35 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No. 102, At & Po. Gavasad, Padra Jambusar Road,, Padra, Gujarat, 391430.
U73100GJ2014PTC081520
081520
12 December 2014
₹7.60 Cr
₹7.55 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Apnar Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Patel | Director | 25 Feb 2015 | Current |
| Dharmesh Bhikhabhai Patel | Director | 24 Jan 2015 | Current |
| Swapnil Kantibhai Patel | Director | 12 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 17 Aug 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apnar Pharma Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Apnar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹503,529,357.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2022 | Others | ₹7.50 Cr | Open |
| 09 Dec 2021 | Others | ₹8.34 M | Open |
| 24 Aug 2020 | Others | ₹1.66 Cr | Open |
| 26 May 2020 | Hdfc Bank Limited | ₹19.87 Cr | Open |
| 16 Dec 2017 | Others | ₹11.49 Cr | Open |
Explore comprehensive loan charge details -
Apnar Pharma has a workforce of 95 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apnar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apnar Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Apnar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Apnar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
A charge with Hdfc Bank Limited of Rs. 19.87 Cr registered on 26 May 2020 with Charge ID 100347326 was modified on 25 Jul 2023. was recorded as a recent event.
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100595339 was registered on 29 Jun 2022. was recorded as a recent event.
Progress on A charge with Others of Rs. 11.49 Cr registered on 16 Dec 2017 with Charge ID 100145635 was modified on 25 Feb 2022. was documented.
The activity A charge with Others amounted to Rs. 0.83 Cr with Charge ID 100519438 was registered on 09 Dec 2021. was completed.
The CIN of Apnar Pharma Private Limited is U73100GJ2014PTC081520.
Apnar Pharma Private Limited is headquartered at Block No. 102, At & Po. Gavasad, Padra Jambusar Road,, Padra, Gujarat, 391430.
Apnar Pharma Private Limited was incorporated on 12 December 2014.
The current directors of Apnar Pharma Private Limited are
The primary industry of Apnar Pharma Private Limited is Professional, Scientific And Technical.
Apnar Pharma Private Limited is unlisted.
The authorized capital of Apnar Pharma Private Limited is ₹7.60 Cr, and the paid-up capital is ₹7.55 Cr.
The compliance status of Apnar Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX